Blade Air Mobility (SRTA): Market Cap to Revenue

Symbol and logo of brand Blade Air Mobility (SRTA)

The partnership between Strata Critical Medical Inc (SRTA) and transplant centers for the air delivery of organs creates strong momentum, which is reflected in the price action. This P/S chart demonstrates a search for balance between price and revenue, where the value of 1.80 fixes the metric level. An asset-light transportation model guarantees stability, while growth potential relies on the development of digital infrastructure and IT systems for emergency medicine.

SRTA Blade Air Mobility P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Strata Critical Medical Corp (SRTA)

- share price and consensus valuation forecast:
General company analysis:SRTA blade.com
Core merchandise of Strata Critical Medical Inc

The P/S ratio reflects the market value of a business relative to its annual turnover, allowing for an assessment of the premium paid for each unit of revenue through the ratio of market capitalization to sales. By analyzing the price-to-sales chart, an investor can align market expectations with the development pace of digital infrastructure and R&D projects at Strata Critical Medical (SRTA) within the emergency aeromedical sector.

Competitors of Strata Critical Medical Inc

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|xtantmedical.com (XTNT) - Price-to-Revenue Ratio|NMTC - Price-to-Revenue Coefficient|Market Cap to Revenue MODD|MYO (Myomo Inc.) - Market Cap to Sales Volume|Price-to-Revenue Ratio Envoy Medical, Inc (COCH)|VVOS (Vivos Therapeutics Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple NVNO (enVVeno Medical)|P/S Multiple Sintx Technologies Inc SINT|TNON: Market Cap to Revenue|ReWalk Robotics - Market Cap to Sales Volume|AMIX: P/S Multiple|INVO Fertility Corp (IVF) - P/S Multiple|Market Cap to Revenue BBLG|AXNX: Market Capitalization-to-Revenue Ratio|P/S Multiple BIOL|Market Cap to Revenue dynatronics.com DYNT|Price-to-Revenue Ratio Paragon 28 FNA|Market Capitalization-to-Revenue Ratio INVO